The epidermal growth factor receptor (EGFR) gene somatic mutations in the kinase domain are the most common targetable gene of NSCLC, which are found in ~40%–58% and 17%–21% of Asian and Caucasian patients, respectively.3, 4, 5. Here, EGFR is linked to non-small cell lung carcinoma.